University of Michigan medtech spin-off Tangent Medical Technologies is now accepting commercial orders of the firm’s NovaCath IV catheter following four years of development. The Ann Arbor-based spin-off said it will begin deliveries of its catheter in the third quarter of the year, beginning next month. To date, Tangent has attracted $13.1m in venture funding…
Michigan spin-off moves to commercialise
Jun 27, 2013 •
LEADERSHIP SOCIETYInforming, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.
More featured content
Resistance is futile: seven superconductor companies that want to change the world
From healthcare to fusion to quantum computing to space, superconductors have the potential to revolutionise the world. And the technology is finally ready to commercialise.
UK universities urged to lower spinout stakes
A new report recommends stakes of less than 25% but fails to address the issue of access to early-stage capital.
Feb 7, 2024
Mar 14, 2024
Monterey, CA (USA)
Jun 26, 2024